Update to Home Office licence will allow London-listed pharmaceuticals group to pursue supply deals

Celadon becomes first UK medical cannabis group to win right to sell in Britain


Celadon Pharmaceuticals has become the first UK-based medical cannabis manufacturer to be granted a Home Office licence to sell its products in the UK since government reforms opened up the industry in 2018.
The London-listed company can now pursue supply deals to sell its cannabis oil to specialist private clinics with the right to prescribe medical cannabis, as well as to universities and pharmaceutical companies conducting research and development.
This story originally appeared on: Financial Times - Author:Oliver Barnes